Kenneth L Urish1, Yongmei Qin2, Benjamin Y Li2, Tudor Borza2, Michael Sessine2, Peter Kirk2, Brent K Hollenbeck2, Jonathan E Helm3, Mariel S Lavieri4, Ted A Skolarus5, Bruce L Jacobs6. 1. Arthritis and Arthroplasty Design Group, The Bone and Joint Center, Magee Womens Hospital of the University of Pittsburgh Medical Center; Department of Orthopaedic Surgery, Department of Bioengineering, and Clinical and Translational Science Institute, University of Pittsburgh; Department of Biomedical Engineering, Carnegie Mellon University, Pittsburgh, Pennsylvania. 2. Division of Oncology, Dow Division for Urologic Health Service Research, Department of Urology, University of Michigan, Ann Arbor, Michigan. 3. Health Services Research & Development, Center for Clinical Management Research, VA Ann Arbor Healthcare System, Ann Arbor, Michigan. 4. Department of Industrial and Operations Engineering, University of Michigan, Ann Arbor, Michigan. 5. Department of Urology, Division of Oncology, Dow Division for Urologic Health Service Research, Health Services Research & Development, Center for Clinical Management Research, VA Ann Arbor Healthcare System, University of Michigan, Ann Arbor, Michigan. 6. Department of Urology, University of Pittsburgh, Pittsburgh, Pennsylvania.
Abstract
BACKGROUND: The Comprehensive Care for Joint Replacement bundle was created to decrease total knee arthroplasty (TKA) cost. To help accomplish this, there is a focus on reducing TKA readmissions. However, there is a lack of national representative sample of all-payer hospital admissions to direct strategy, identify risk factors for readmission, and understand actual readmission cost. METHODS: We used the Nationwide Readmission Database to examine national readmission rates, predictors of readmission, and associated readmission costs for elective TKA procedures. We fit a multivariable logistic regression model to examine factors associated with readmission. Then, we determined mean readmission costs and calculated the readmission cost when distributed across the entire TKA population. RESULTS: We identified 224,465 patients having TKA across all states participating in the Nationwide Readmission Database. The mean unadjusted 30-day TKA readmission rate was 4%. The greatest predictors of readmission were congestive heart failure (odds ratio [OR] 2.51, 95% confidence interval [CI] 2.62-2.80), renal disease (OR 2.19, 95% CI 2.03-2.37), and length of stay greater than 4 days (OR 2.4, 95% CI 2.25-2.61). The overall median cost for each readmission was $6753 ± 175. Extrapolating the readmission cost for the entire TKA population resulted in the readmission cost being 2% of the overall 30-day procedure cost. CONCLUSIONS: A major focus of the Comprehensive Care for Joint Replacement bundle is improving cost and quality by limiting readmission rates. TKA readmissions are low and comprise a small percentage of total TKA cost, suggesting that they may not be the optimal measure of quality care or a significant driver of overall cost.
BACKGROUND: The Comprehensive Care for Joint Replacement bundle was created to decrease total knee arthroplasty (TKA) cost. To help accomplish this, there is a focus on reducing TKA readmissions. However, there is a lack of national representative sample of all-payer hospital admissions to direct strategy, identify risk factors for readmission, and understand actual readmission cost. METHODS: We used the Nationwide Readmission Database to examine national readmission rates, predictors of readmission, and associated readmission costs for elective TKA procedures. We fit a multivariable logistic regression model to examine factors associated with readmission. Then, we determined mean readmission costs and calculated the readmission cost when distributed across the entire TKA population. RESULTS: We identified 224,465 patients having TKA across all states participating in the Nationwide Readmission Database. The mean unadjusted 30-day TKA readmission rate was 4%. The greatest predictors of readmission were congestive heart failure (odds ratio [OR] 2.51, 95% confidence interval [CI] 2.62-2.80), renal disease (OR 2.19, 95% CI 2.03-2.37), and length of stay greater than 4 days (OR 2.4, 95% CI 2.25-2.61). The overall median cost for each readmission was $6753 ± 175. Extrapolating the readmission cost for the entire TKA population resulted in the readmission cost being 2% of the overall 30-day procedure cost. CONCLUSIONS: A major focus of the Comprehensive Care for Joint Replacement bundle is improving cost and quality by limiting readmission rates. TKA readmissions are low and comprise a small percentage of total TKA cost, suggesting that they may not be the optimal measure of quality care or a significant driver of overall cost.
Authors: Mark I Froimson; Adam Rana; Richard E White; Amanda Marshall; Steve F Schutzer; William L Healy; Peggy Naas; Gail Daubert; Richard Iorio; Brian Parsley Journal: J Arthroplasty Date: 2013-09 Impact factor: 4.757
Authors: Youssef F El Bitar; Kenneth D Illingworth; Steven L Scaife; John V Horberg; Khaled J Saleh Journal: J Arthroplasty Date: 2015-05-08 Impact factor: 4.757
Authors: Bheeshma Ravi; Ruth Croxford; Peter C Austin; Simon Hollands; J Michael Paterson; Earl Bogoch; Hans Kreder; Gillian A Hawker Journal: Arthritis Rheumatol Date: 2014-03 Impact factor: 10.995
Authors: Steven M Kurtz; Edmund C Lau; Kevin L Ong; Edward M Adler; Frank R Kolisek; Michael T Manley Journal: J Arthroplasty Date: 2016-04-04 Impact factor: 4.757
Authors: Nicholas P Drain; Valerie C Gobao; Dominique M Bertolini; Clair Smith; Neel B Shah; Scott D Rothenberger; Malcolm E Dombrowski; Michael J O'Malley; Brian A Klatt; Brian R Hamlin; Kenneth L Urish Journal: J Arthroplasty Date: 2020-03-04 Impact factor: 4.757
Authors: Andrew D Kleven; Austin H Middleton; Ziynet Nesibe Kesimoglu; Isaac C Slagel; Ashley E Creager; Ryan Hanson; Serdar Bozdag; Adam I Edelstein Journal: J Arthroplasty Date: 2021-12-22 Impact factor: 4.757
Authors: Alexander von Glinski; Emre Yilmaz; Ryan Goodmanson; Clifford Pierre; Sven Frieler; Andre Shaffer; Basem Ishak; Cara Beth Lee; Keith Mayo Journal: J Hip Preserv Surg Date: 2020-02-24
Authors: Kenneth L Urish; Yongmei Qin; Bassel Salka; Benjamin Y Li; Tudor Borza; Michael Sessine; Peter Kirk; Brent K Hollenbeck; Jonathan E Helm; Mariel S Lavieri; Ted A Skolarus; Bruce L Jacobs Journal: Ann Transl Med Date: 2020-06
Authors: Amer N Kadri; Hasan Abuamsha; Leen Nusairat; Nazih Kadri; Hussam Abuissa; Ahmad Masri; Adrian V Hernandez Journal: J Am Heart Assoc Date: 2018-09-18 Impact factor: 5.501